医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
DFTX · Definium Therapeutics, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Definium Therapeutics, Inc.（DFTX）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $3.0M；高管董事有效买入 —、有效卖出 —。最近申报 2026-09-29。
买入 Bought—
卖出 Sold$3.0M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-25 | Barrow Robert Chief Executive Officer, Director | 卖出 Sell | 31,550 | $36.57 | $1.2M | SEC |
| 2026-09-25 | Roberts Brandi Chief Financial Officer | 卖出 Sell | 3,377 | $36.57 | $123K | SEC |
| 2026-09-25 | Sullivan Mark Chief Legal Officer | 卖出 Sell | 14,051 | $36.57 | $514K | SEC |
| 2026-09-25 | Wiley Matthew T. Chief Commercial Officer | 卖出 Sell | 3,097 | $36.57 | $113K | SEC |
| 2026-09-25 | Karlin Daniel Chief Medical Officer, Director | 卖出 Sell | 10,853 | $36.57 | $397K | SEC |
| 2026-09-03 | Barrow Robert Chief Executive Officer, Director | 卖出 Sell | 19,023 | $37.94 | $722K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-25 | Barrow Robert Officer, Director | 31,550 | $1.2M | |
| 2026-09-25 | Sullivan Mark Officer | 14,051 | $516K | |
| 2026-09-25 | Karlin Daniel Officer | 10,853 | $399K | |
| 2026-09-25 | Roberts Brandi Officer | 3,377 | $124K | |
| 2026-09-25 | Wiley Matthew T. Officer | 3,097 | $114K | |
| 2026-09-03 | Barrow Robert Officer, Director | 19,023 | $718K |
内部人 Insiders
Barrow Robert、Roberts Brandi、Sullivan Mark、Wiley Matthew T.、Karlin Daniel